Friedman Paul A
Director at MDGL; Director at INCY; Director at AUXILIUM PHARMACEUTICALS INC
- Sold, on record
- $324M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Jan 9, 2026
- Form 144 notices
- 8
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Director
- INCYINCYTE CORPDirector
- AUXILIUM PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INCY2.5M shares
- MDGL429,382 shares
- AUXILIUM PHARMACEUTICALS INC29,689 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 144 notice MDGLNoticeAug 12, 2025 2025
Filed to sell 43,605 shares ($15.2M)
Friedman Paul A, Director
10b5-1 plan1.6x usual sizeFiling
- 2 Form 4 sale MDGLRoutineAug 12, 2025 same day
Sold 46,808 shares at $355.31 ($16.6M)
Friedman Paul A, Director
10b5-1 planSold 20% of holdings ($83.1M position)187,164 shares left1.7x usual sizeFollows a Form 144Filing
- 3 Form 144 notice MDGLNoticeAug 13, 2025 +1 day
Filed to sell 129,172 shares ($46.4M)
Friedman Paul A, Director
10b5-1 plan4.5x usual sizeFiling
- 4 Form 4 sale MDGLUnusualAug 13, 2025 same day
Sold 129,172 shares at $370.24 ($47.8M)
Friedman Paul A, Director
10b5-1 planSold 40.8% of holdings ($117M position)187,164 shares left4.5x usual sizeFollows a Form 144Filing
- 5 Form 144 notice MDGLNoticeDec 10, 2025 +119 days
Filed to sell 49,600 shares ($27.5M)
Friedman Paul A, Director
10b5-1 plan1.3x usual sizeFiling
- 6 Form 4 sale MDGLRoutineDec 10, 2025 same day
Sold 24,800 shares at $552.18 ($13.7M)
Friedman Paul A, Director
10b5-1 planSold 11.7% of holdings ($117M position)187,164 shares left0.7x usual sizeFollows a Form 144Filing
- 7 Form 4 sale MDGLRoutineJan 9, 2026 +30 days
Sold 24,520 shares at $522.39 ($12.8M)
Friedman Paul A, Director
10b5-1 planSold 11.6% of holdings ($111M position)187,164 shares left0.8x usual sizeFollows a Form 144Filing
- 8 Form 4 sale MDGLRoutineJan 9, 2026 same day
Sold 280 shares at $551.24 ($154k)
Friedman Paul A, Director
10b5-1 planSold 0.1% of holdings ($103M position)187,164 shares left0x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (32)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | Jan 13, 2026 | MDGL | Director | Form 4 sale | 280 | $154k | 0.1% | Routine | SEC |
| Jan 9, 2026 | Jan 13, 2026 | MDGL | Director | Form 4 sale | 24,520 | $12.8M | 11.6% | Routine | SEC |
| Dec 10, 2025 | Dec 12, 2025 | MDGL | Director | Form 4 sale | 24,800 | $13.7M | 11.7% | Routine | SEC |
| Dec 10, 2025 | Dec 10, 2025 | MDGL | Director | Form 144 notice | 49,600 | $27.5M | Notice | SEC | |
| Aug 13, 2025 | Aug 13, 2025 | MDGL | Director | Form 4 sale | 129,172 | $47.8M | 40.8% | Unusual | SEC |
| Aug 13, 2025 | Aug 13, 2025 | MDGL | Director | Form 144 notice | 129,172 | $46.4M | Notice | SEC | |
| Aug 12, 2025 | Aug 13, 2025 | MDGL | Director | Form 4 sale | 46,808 | $16.6M | 20.0% | Routine | SEC |
| Aug 12, 2025 | Aug 12, 2025 | MDGL | Director | Form 144 notice | 43,605 | $15.2M | Notice | SEC | |
| Aug 11, 2025 | Aug 11, 2025 | MDGL | Director | Form 144 notice | 3,203 | $1.1M | Notice | SEC | |
| Jul 18, 2025 | Jul 22, 2025 | MDGL | Director | Form 4 sale | 1,400 | $490k | 0.7% | Routine | SEC |
| Jul 18, 2025 | Jul 18, 2025 | MDGL | Director | Form 144 notice | 1,400 | $488k | Notice | SEC | |
| Jul 17, 2025 | Jul 18, 2025 | MDGL | Director | Form 4 sale | 28,876 | $10.2M | 13.4% | Routine | SEC |
| Jul 17, 2025 | Jul 17, 2025 | MDGL | Director | Form 144 notice | 2,700 | $931k | Notice | SEC | |
| Jul 16, 2025 | Jul 16, 2025 | MDGL | Director | Form 144 notice | 26,176 | $8.1M | Notice | SEC | |
| Apr 8, 2024 | Apr 10, 2024 | MDGL | Director | Form 4 sale | 26,270 | $6.5M | 12.4% | Routine | SEC |
| Apr 5, 2024 | Apr 5, 2024 | MDGL | Director | Form 4 sale | 73,730 | $18M | 28.4% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | MDGL | Director, Officer | Form 144 notice | 100,000 | $24.4M | Notice | SEC | |
| Aug 6, 2019 | Aug 6, 2019 | INCY | Director | Form 4 sale | 100,000 | $8.3M | 28.1% | Unusual | SEC |
| Jun 11, 2018 | Jun 12, 2018 | MDGL | Chief Executive Officer | Form 4 sale | 73,526 | $21.1M | 10.1% | Plan not stated | SEC |
| Nov 16, 2017 | Nov 20, 2017 | INCY | Director | Form 4 sale | 28,507 | $3M | 9.6% | Plan not stated | SEC |
| Mar 17, 2017 | Mar 20, 2017 | INCY | Director | Form 4 sale | 50,000 | $7.4M | 14.4% | Plan not stated | SEC |
| Feb 23, 2017 | Feb 27, 2017 | INCY | Director | Form 4 sale | 50,000 | $6M | 14.4% | Plan not stated | SEC |
| Nov 18, 2015 | Nov 19, 2015 | INCY | Director | Form 4 sale | 225,000 | $25.6M | 43.1% | Unusual | SEC |
| May 27, 2015 | May 28, 2015 | INCY | Director | Form 4 sale | 196,751 | $21.1M | 39.8% | Unusual | SEC |
| May 22, 2015 | May 26, 2015 | INCY | Director | Form 4 sale | 102,243 | $11.1M | 25.6% | Unusual | SEC |
| Feb 13, 2015 | Feb 18, 2015 | INCY | Director | Form 4 sale | 120,000 | $8.9M | 28.7% | Unusual | SEC |
| Dec 5, 2014 | Dec 8, 2014 | AUXILIUM PHARMACEUTICALS INC | Director | Form 4 sale | 29,689 | $1M | 74.1% | Unusual | SEC |
| Nov 6, 2014 | Nov 7, 2014 | INCY | Director | Form 4 sale | 185,653 | $12.6M | 30.8% | Unusual | SEC |
| Feb 20, 2014 | Feb 21, 2014 | INCY | Director | Form 4 sale | 33,354 | $2.1M | 7.4% | Plan not stated | SEC |
| Feb 19, 2014 | Feb 19, 2014 | INCY | Director | Form 4 sale | 771,182 | $50.6M | 64.9% | Unusual | SEC |
| Sep 10, 2013 | Sep 12, 2013 | INCY | Chief Executive Officer | Form 4 sale | 376,789 | $14.1M | 49.0% | Unusual | SEC |
| May 7, 2012 | May 8, 2012 | INCY | Chief Executive Officer | Form 4 sale | 225,000 | $5.1M | 42.1% | Unusual | SEC |